Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

First Affiliated Hospital Of Guangxi Medical University

Clinical trials sponsored by First Affiliated Hospital Of Guangxi Medical University, explained in plain language.

Trials to join now! 1 Not yet recruiting 6 Not yet finished but already full! 1 Terminated 1

New combo aims to shrink tough colon cancers before surgery

Disease control Ongoing

This study tests whether adding the immunotherapy drug tislelizumab to standard chemotherapy before surgery can help people with a common type of colon cancer (MSS, locally advanced). About 60 adults will receive the combination, then have surgery to remove the tumor. The main go…

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control

Last updated May 15, 2026 12:07 UTC